Jeffrey Lieberman

1.1k total citations
21 papers, 432 citations indexed

About

Jeffrey Lieberman is a scholar working on Psychiatry and Mental health, Neurology and Pharmacology. According to data from OpenAlex, Jeffrey Lieberman has authored 21 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Neurology and 3 papers in Pharmacology. Recurrent topics in Jeffrey Lieberman's work include Schizophrenia research and treatment (4 papers), Electroconvulsive Therapy Studies (3 papers) and Cannabis and Cannabinoid Research (2 papers). Jeffrey Lieberman is often cited by papers focused on Schizophrenia research and treatment (4 papers), Electroconvulsive Therapy Studies (3 papers) and Cannabis and Cannabinoid Research (2 papers). Jeffrey Lieberman collaborates with scholars based in United States, United Kingdom and Austria. Jeffrey Lieberman's co-authors include Manzar Ashtari, Gustav Degreef, Bernhard Bogerts, George Lantos, Patrick F. Sullivan, Pamela Sklar, S. Geisler, A. John Rush, Roy H. Perlis and Houwei Wu and has published in prestigious journals such as American Journal of Psychiatry, Schizophrenia Research and American Journal of Neuroradiology.

In The Last Decade

Jeffrey Lieberman

20 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey Lieberman United States 9 170 118 107 82 81 21 432
Helen E. Courvoisie United States 6 204 1.2× 46 0.4× 84 0.8× 39 0.5× 34 0.4× 7 300
Eline M. P. Poels United States 11 168 1.0× 99 0.8× 145 1.4× 60 0.7× 22 0.3× 18 511
Kathryn I. Alpert United States 14 163 1.0× 139 1.2× 222 2.1× 40 0.5× 19 0.2× 17 486
Mariken B. de Koning Netherlands 9 171 1.0× 103 0.9× 123 1.1× 28 0.3× 31 0.4× 21 322
Guanglei Xun China 11 144 0.8× 113 1.0× 318 3.0× 33 0.4× 49 0.6× 20 476
Christian Núñez Spain 12 151 0.9× 42 0.4× 86 0.8× 41 0.5× 40 0.5× 30 355
Carla Morganti Italy 10 284 1.7× 76 0.6× 150 1.4× 13 0.2× 133 1.6× 17 477
Daniel A. Rinker United States 8 75 0.4× 109 0.9× 202 1.9× 41 0.5× 41 0.5× 9 376
A. Boccio United States 7 292 1.7× 142 1.2× 229 2.1× 18 0.2× 91 1.1× 11 458
Stephen Giles United Kingdom 10 235 1.4× 127 1.1× 220 2.1× 31 0.4× 57 0.7× 16 425

Countries citing papers authored by Jeffrey Lieberman

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Lieberman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Lieberman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Lieberman more than expected).

Fields of papers citing papers by Jeffrey Lieberman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Lieberman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Lieberman. The network helps show where Jeffrey Lieberman may publish in the future.

Co-authorship network of co-authors of Jeffrey Lieberman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Lieberman. A scholar is included among the top collaborators of Jeffrey Lieberman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Lieberman. Jeffrey Lieberman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Javitt, Daniel C., Cameron S. Carter, Joshua T. Kantrowitz, et al.. (2019). A multicenter study of ketamine effects on functional connectivity: Large scale network relationships, hubs and symptom mechanisms. NeuroImage Clinical. 22. 101739–101739. 24 indexed citations
2.
Lieberman, Jeffrey. (2017). The Dangerous Case of Psychiatrists Writing About the POTUS’s Mental Health. Psychiatric News. 52(22). 2 indexed citations
3.
Dixon, Lisa & Jeffrey Lieberman. (2014). Psychiatry Embraces Patient-Centered Care. Psychiatric News. 49(3). 1–1. 3 indexed citations
4.
Chowdhury, Nabilah I., Arun K. Tiwari, Eva J. Brandl, et al.. (2014). Poster #T48 INVESTIGATION OF THE PRO-MELANIN-CONCENTRATING HORMONE GENE IN ANTIPSYCHOTIC INDUCED WEIGHT GAIN. Schizophrenia Research. 153. S306–S306. 1 indexed citations
5.
DuPont, Robert L. & Jeffrey Lieberman. (2014). Marijuana Legalization and Young Brains: Time for Serious Study. Psychiatric News. 49(8). 1–1.
6.
Lieberman, Jeffrey. (2013). Psychiatry: Nothing to Be Defensive About. Psychiatric News. 48(14). 1–1. 1 indexed citations
7.
Lieberman, Jeffrey, et al.. (2013). Training the Psychiatrist of the Future. Psychiatric News. 48(23). 1–1. 1 indexed citations
8.
Vadhan, Nehal P., Cheryl M. Corcoran, Gillinder Bedi, Jeffrey Lieberman, & Margaret Haney. (2013). Marijuana smokers at clinical high-risk for schizophrenia exhibit an enhanced subjective, behavioral and physiological response to smoked marijuana. Comprehensive Psychiatry. 54(8). e37–e37. 2 indexed citations
9.
Huang, Jie, Roy H. Perlis, Sang Hyuck Lee, et al.. (2010). Cross-Disorder Genomewide Analysis of Schizophrenia, Bipolar Disorder, and Depression. American Journal of Psychiatry. 167(10). 1254–1263. 148 indexed citations
10.
Jin, Yuyan, Bruce G. Pollock, Kim C. Coley, et al.. (2009). Population Pharmacokinetics of Perphenazine in Schizophrenia Patients From CATIE: Impact of Race and Smoking. The Journal of Clinical Pharmacology. 50(1). 73–80. 20 indexed citations
11.
Waltrip, Royce W., Jeffrey Lieberman, Delbert G. Robinson, et al.. (1997). First episode schizophrenia and borna disease virus. Schizophrenia Research. 24(1-2). 261–261. 1 indexed citations
12.
Miller, Carl H., Fritz Mohr, Daniel Umbricht, et al.. (1997). The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone and conventional antipsychotics. Schizophrenia Research. 24(1-2). 265–266. 3 indexed citations
13.
Woerner, Margaret G., A. Koreen, Samuel G. Siris, et al.. (1995). Dr. Robinson and Colleagues Reply. American Journal of Psychiatry. 152(3). 476–a. 11 indexed citations
14.
Szymanski, S., et al.. (1993). A Selective Review of Recent Advances in the Management of Tardive Dyskinesia. Psychiatric Annals. 23(4). 209–215. 6 indexed citations
15.
Degreef, Gustav, George Lantos, Bernhard Bogerts, Manzar Ashtari, & Jeffrey Lieberman. (1992). Abnormalities of the septum pellucidum on MR scans in first-episode schizophrenic patients.. American Journal of Neuroradiology. 13(3). 835–40. 92 indexed citations
16.
Degreef, Gustav, Manzar Ashtari, Houwei Wu, et al.. (1991). 15. Follow up MRI study in first episode schizophrenia. Schizophrenia Research. 5(3). 204–206. 71 indexed citations
17.
Yadalam, Kashinath, et al.. (1989). CT morphology and short term outcome in schizophrenia. Schizophrenia Research. 2(1-2). 137–137. 1 indexed citations
18.
Lieberman, Jeffrey. (1984). Evidence for a Biological Hypothesis of Obsessive-Compulsive Disorder. Neuropsychobiology. 11(1). 14–21. 23 indexed citations
19.
Kane, John M., Margaret G. Woerner, P Weinhold, et al.. (1983). Epidemiology of Tardive Dyskinesia. Clinical Neuropharmacology. 6(2). 109–116. 12 indexed citations
20.
Lieberman, Jeffrey. (1981). Cholinergic rebound in neuroleptic withdrawal syndromes. Psychosomatics. 22(3). 253–254. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen E. Courvoisie Breakdown of academic impact, for papers by Eline M. P. Poels Breakdown of academic impact, for papers by Kathryn I. Alpert Breakdown of academic impact, for papers by Mariken B. de Koning Breakdown of academic impact, for papers by Guanglei Xun Breakdown of academic impact, for papers by Christian Núñez Breakdown of academic impact, for papers by Carla Morganti Breakdown of academic impact, for papers by Daniel A. Rinker Breakdown of academic impact, for papers by A. Boccio Breakdown of academic impact, for papers by Stephen Giles
Rankless by CCL
2026